capital raise

Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

Dave Bloom - 2023/05/11

Company is developing UTULY for intranasal emergency epinephrine delivery.

Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial

Dave Bloom - 2022/02/10

No significant adverse events in any patient during ongoing Phase 1 trial.

ZEGO Press Release

Dave Bloom - 2018/02/13

ZEGO Snacks Emerges as 'De Facto Leader in Allergen Transparency'

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: capital raise

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial

ZEGO Press Release